Teva Announces Signing of New $3B Syndicated Revolving Credit Line
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it has entered into a new five-year, $3.0 billion unsecured revolving credit facility, which replaces its existing $2.5 billion credit facility.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.